Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$198.88 - $227.6 $333,124 - $381,230
-1,675 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$212.27 - $248.7 $124,814 - $146,235
-588 Reduced 25.98%
1,675 $356,000
Q2 2021

Aug 11, 2021

SELL
$233.58 - $259.14 $26,861 - $29,801
-115 Reduced 4.84%
2,263 $551,000
Q1 2021

May 10, 2021

SELL
$221.91 - $258.6 $57,252 - $66,718
-258 Reduced 9.79%
2,378 $591,000
Q4 2020

Feb 02, 2021

SELL
$216.38 - $257.67 $80,493 - $95,853
-372 Reduced 12.37%
2,636 $606,000
Q3 2020

Nov 05, 2020

SELL
$234.65 - $260.95 $92,452 - $102,814
-394 Reduced 11.58%
3,008 $765,000
Q2 2020

Aug 10, 2020

SELL
$197.81 - $242.74 $69,629 - $85,444
-352 Reduced 9.38%
3,402 $802,000
Q1 2020

May 08, 2020

SELL
$182.24 - $241.7 $100,778 - $133,660
-553 Reduced 12.84%
3,754 $761,000
Q4 2019

Feb 10, 2020

SELL
$189.21 - $243.2 $198,670 - $255,360
-1,050 Reduced 19.6%
4,307 $1.04 Million
Q3 2019

Oct 28, 2019

SELL
$174.11 - $208.62 $99,242 - $118,913
-570 Reduced 9.62%
5,357 $1.04 Million
Q2 2019

Jul 18, 2019

SELL
$166.7 - $195.41 $572,281 - $670,842
-3,433 Reduced 36.68%
5,927 $1.09 Million
Q1 2019

Apr 09, 2019

SELL
$180.87 - $203.88 $127,332 - $143,531
-704 Reduced 7.0%
9,360 $1.78 Million
Q4 2018

Feb 07, 2019

SELL
$178.4 - $208.25 $184,287 - $215,122
-1,033 Reduced 9.31%
10,064 $1.96 Million
Q3 2018

Nov 02, 2018

SELL
$185.29 - $208.89 $1.36 Million - $1.53 Million
-7,317 Reduced 39.74%
11,097 $2.3 Million
Q2 2018

Jul 25, 2018

BUY
$166.05 - $186.51 $139,980 - $157,227
843 Added 4.8%
18,414 $3.4 Million
Q1 2018

May 08, 2018

SELL
$169.43 - $198.0 $51,506 - $60,192
-304 Reduced 1.7%
17,571 $3 Million
Q4 2017

Feb 05, 2018

SELL
$168.79 - $188.59 $285,423 - $318,905
-1,691 Reduced 8.64%
17,875 $3.11 Million
Q3 2017

Oct 17, 2017

BUY
$167.29 - $191.0 $3.27 Million - $3.74 Million
19,566
19,566 $3.65 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bank Of The West Portfolio

Follow Bank Of The West and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of The West, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of The West with notifications on news.